TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	129.58	153.39	178.05	151.6	287.73	305.66
Trading Asset Securities	3.36	8.43	-	-	-	-
Cash & Short-Term Investments	132.94	161.83	178.05	151.6	287.73	305.66
Cash Growth	-14.05%	-9.11%	17.44%	-47.31%	-5.87%	68.44%
Accounts Receivable	352.86	405.27	735.89	893.69	1,033	1,382
Other Receivables	123.36	122.24	258.93	307.38	294.37	296.99
Receivables	476.22	527.51	994.82	1,201	1,327	1,679
Inventory	240.31	224.71	223.77	159.63	239.74	105.95
Other Current Assets	226.15	212.43	56.16	115.17	59.85	132.42
Total Current Assets	1,076	1,126	1,453	1,627	1,914	2,223
Property, Plant & Equipment	563.84	533.42	533.56	521.79	361.86	233.26
Long-Term Investments	101.95	101.87	97.5	101.67	255.83	96.63
Goodwill	1.52	1.52	2.08	5.56	5.56	5
Other Intangible Assets	24.9	25.15	26.15	7.12	7.82	104.93
Long-Term Accounts Receivable	-	-	613.03	452.24	309.12	129.08
Long-Term Deferred Tax Assets	102.19	102.05	105.4	109.43	92.12	46.83
Long-Term Deferred Charges	8.92	5.62	4.95	5.3	4.65	3.59
Other Long-Term Assets	990.29	997.03	279.51	342.06	409.89	486.69
Total Assets	2,869	2,893	3,215	3,273	3,461	3,329
Accounts Payable	624.86	683.15	638.33	684	666.01	684.18
Accrued Expenses	33.79	29.94	28.24	19.38	16.59	6.62
Short-Term Debt	91.1	91.08	128.23	168.35	152.76	216.34
Current Portion of Long-Term Debt	153.31	193.22	115.51	77.61	39.39	311.02
Current Portion of Leases	-	-	35.94	25.94	33.71	6.31
Current Income Taxes Payable	2.72	3.8	0.05	-	1.35	2.28
Current Unearned Revenue	81.36	79.15	144.65	82.5	71.63	80.07
Other Current Liabilities	226.58	245.29	255.4	180.37	149.4	117.15
Total Current Liabilities	1,214	1,326	1,346	1,238	1,131	1,424
Long-Term Debt	694.86	692.14	753.37	751.37	649.16	212.11
Long-Term Leases	91.55	64.76	247.13	281.18	209.79	41
Long-Term Unearned Revenue	0.59	0.61	0.69	-	-	-
Long-Term Deferred Tax Liabilities	2.39	2.45	2.68	0.07	0.26	0.58
Other Long-Term Liabilities	278.22	213.91	156.24	167.5	36.79	39.59
Total Liabilities	2,281	2,299	2,506	2,438	2,027	1,717
Common Stock	290.15	290.15	290.15	290.15	290.15	290.15
Additional Paid-In Capital	893.35	912.8	912.21	931.77	931.9	930.16
Retained Earnings	-801.04	-790.52	-683.62	-576.26	-81.85	197.55
Total Common Equity	382.46	412.42	518.74	645.66	1,140	1,418
Minority Interest	205.45	181.22	189.79	188.69	293.53	193.73
Shareholders' Equity	587.9	593.64	708.53	834.35	1,434	1,612
Total Liabilities & Equity	2,869	2,893	3,215	3,273	3,461	3,329
Total Debt	1,031	1,041	1,280	1,304	1,085	786.78
Net Cash (Debt)	-897.88	-879.37	-1,102	-1,153	-797.09	-481.12
Net Cash Per Share	-3.09	-3.03	-3.80	-3.97	-3.30	-1.81
Filing Date Shares Outstanding	289.77	-	290.15	290.15	290.15	290.15
Total Common Shares Outstanding	289.77	-	290.15	290.15	290.15	290.15
Working Capital	-138.09	-199.15	106.45	389.31	783.56	798.86
Book Value Per Share	1.32	-	1.79	2.23	3.93	4.89
Tangible Book Value	356.04	385.76	490.5	632.98	1,127	1,308
Tangible Book Value Per Share	1.23	-	1.69	2.18	3.88	4.51
Buildings	-	-	150.56	98.24	7.96	176.46
Machinery	-	-	245.82	209.27	88.56	31.86
Construction In Progress	-	-	21.37	19.06	7.37	3.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.